Works matching AU Olsson, Anders G


Results: 31
    1
    2
    3
    4
    5
    6
    7
    8

    High-Dose Statins and the IDEAL Study.

    Published in:
    2006
    By:
    • Pedersen, Terje R.;
    • Faergeman, Ole;
    • Kastelein, John J. P.;
    • Olsson, Anders G.;
    • Tikkanen, Matti J.;
    • Holme, Ingar;
    • Larsen, Mogens Lytken;
    • Bendiksen, Fredrik S.
    Publication type:
    Letter
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    RE: Praluent (Alirocumab)-Induced Renal Injury.

    Published in:
    Journal of Pharmacy Practice, 2018, v. 31, n. 2, p. 138, doi. 10.1177/0897190017734429
    By:
    • Rosenson, Robert S.;
    • Larrey, Dominique;
    • Waters, David D.;
    • Olsson, Anders G.
    Publication type:
    Article
    22
    23
    24

    A new statin: A new standard.

    Published in:
    Clinical Cardiology, 2001, v. 24, n. S3, p. 18, doi. 10.1002/clc.4960241505
    By:
    • Olsson, Anders G.
    Publication type:
    Article
    25
    26
    27
    28
    29
    30

    Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL).

    Published in:
    Annals of Medicine, 2008, v. 40, n. 6, p. 456, doi. 10.1080/07853890801964955
    By:
    • Holme, Ingar;
    • Cater, Nilo B.;
    • Faergeman, Ole;
    • Kastelein, John J. P.;
    • Olsson, Anders G.;
    • Tikkanen, Matti J.;
    • Lytken Larsen, Mogens;
    • Lindahl, Christina;
    • Pedersen, Terje R.;
    • on behalf of the Incremental Decrease in End-Points Through Aggressive Lipid-Lowering Study Group
    Publication type:
    Article
    31